
1. Technology overview
Amplifai Health is a Saudi-based healthtech company, reported by an Arab business outlet as founded in 2023, that combines AI with thermal imaging. Its news page lists SFDA approval in February 2025 for a software as a medical device for diabetic foot screening, ISO 13485 certification in July 2024, and a registration with NUPCO in September 2025.
TFScan consists of a portable thermal camera, an AI application, a patient report and a clinical portal. Clinicians capture thermographic scans of the feet, the software flags risks and abnormalities and gives a risk score based on IWGDF guidelines, and dashboards track patients over time. It supports HL7 and EMR/EHR integration and runs on managed tablets with Wi-Fi, LTE and offline mode.
2. Highlighted features & specifications
- Thermal capture: portable thermal camera captures foot thermographic scans in seconds.
- AI risk analysis: automated image quality checks and a risk score based on IWGDF guidelines.
- Patient report: personalized reports for patients.
- Clinical portal: manages patients and integrates with other systems.
- Interoperability: HL7 compatibility and EMR/EHR integration.
- Population analytics: dashboards that show risk trends across demographics.
3. Potential application
Endocrinology clinics and hospitals in Vietnam can screen diabetic patients for foot risk during routine visits. Community health centers can use the portable kit in chronic disease programs. Health insurers and employers can track foot risk at population level.
4. Benefits
Screens for early signs of diabetic foot ulcers at the point of care, with scans taking seconds. Produces explainable reports and a risk score aligned with IWGDF guidelines. Integrates with EMR/EHR and hospital systems through HL7. Population dashboards show risk trends across demographics for programs and payers.
5. Market trends & opportunities
Diabetic foot ulcers are a major cause of amputation, and screening at primary care level remains limited. Governments in the Gulf are funding digital screening programs, and the company lists deployments in Saudi Arabia, the UAE and Bahrain. Vietnam has a rising diabetic population and may need low-cost point-of-care screening.
6. Other information
Saudi-based; founded 2023 per a press article. News page lists SFDA approval (2025-02), a funding round with Wa'ed Ventures, Plug and Play and KAUST Innovation Ventures, ISO 13485 (2024-07), NUPCO registration (2025-09) and awards at FII9 and G20 events. Also sells NUR for sports and recovery.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































